Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	112	56	308	617	880	1,261
Market Cap Growth	90.32%	-81.89%	-50.18%	-29.87%	-30.20%	-
Enterprise Value	-1	-121	61	253	619	917
Last Close Price	2.59	1.31	7.30	14.71	21.09	34.30
PS Ratio	9.33	1.04	6.02	4.68	115.82	9341.04
PB Ratio	0.97	0.37	1.45	2.21	3.05	4.40
P/TBV Ratio	0.97	0.37	1.45	2.21	3.05	4.40
P/OCF Ratio	-	-	-	1916.94	-	-
EV/Sales Ratio	-	-	1.20	1.92	81.46	6794.23
Debt / Equity Ratio	0.00	0.01	0.02	0.02	0.03	0.01
Asset Turnover	0.07	0.25	0.17	0.36	0.02	0.00
Quick Ratio	10.40	6.53	6.11	4.43	9.84	30.86
Current Ratio	10.71	6.77	6.24	4.50	10.02	31.47
Return on Equity (ROE)	-49.78%	-46.63%	-38.16%	-10.23%	-37.17%	-28.36%
Return on Assets (ROA)	-29.72%	-26.76%	-23.51%	-3.38%	-18.71%	-14.76%
Return on Capital Employed (ROCE)	-68.80%	-60.90%	-54.10%	-6.90%	-32.60%	-15.70%
Earnings Yield	-64.67%	-152.08%	-30.50%	-4.71%	-12.15%	-4.24%
FCF Yield	-62.83%	-137.27%	-41.98%	-0.04%	-9.94%	-0.66%
Buyback Yield / Dilution	-1.02%	-0.76%	-0.41%	-10.85%	-88.66%	-1211.56%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q